Skip to main content
Clinical Trials/NCT04015323
NCT04015323
Completed
Not Applicable

The Efficacy of Interferential Current Treatment on Knee Osteoarthritis: A Randomized Double Blind Study That Compares the Effects of Different Carrier Frequencies

Ege University1 site in 1 country61 target enrollmentJuly 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Knee Osteoarthritis
Sponsor
Ege University
Enrollment
61
Locations
1
Primary Endpoint
Change in pain scores according to visual analog scale (VAS)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The effects of different carrier frequencies of interferential current on pain and function in patients with knee arthrosis will be compared

Detailed Description

60 patients with knee osteoarhthritis will be enrolled in the study. Subjects will be randomized to 3 groups. All patients will receive interferential currents to both their knees, with different carrier frequencies (2, 4 and 8 kilohertz (kHz) respectively). The effect of different types of carrier frequencies on pain, 10 meter walk test will be analysed.

Registry
clinicaltrials.gov
Start Date
July 1, 2019
End Date
December 1, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Benil Nesli Ata, MD

Principal Inversitagor

Ege University

Eligibility Criteria

Inclusion Criteria

  • Age between 50-80 years
  • Knee VAS pain scores ≥ 4
  • Kellgren-Lawrence radiologic scores 2 and 3

Exclusion Criteria

  • History of knee surgery
  • Inflammatory arthritis
  • Paralysis of lower extremities
  • Serious cardiovascular disease /presence of cardiac pacemaker
  • Severe osteoarhthritis of lower extremity joints other than the knees
  • History of newly diagnosed cancer (ın the last 6 months)
  • Cognitive impairment

Outcomes

Primary Outcomes

Change in pain scores according to visual analog scale (VAS)

Time Frame: At baseline, on the 3rd week visit (last day of interference therapy) and on the 7th week visit

A visual analog scale value between 0-10. 0 meaning lack of pain and 10 meaning the worst pain the patient has experienced.

Secondary Outcomes

  • Change in the number of paracetamol tablets taken in a week(At baseline, on the 3rd week visit (last day of interference therapy) and on the 7th week visit)
  • Change in pain status levels according to Western Ontario and McMaster Universities Arhtiritis Incex (WOMAC) scale(At baseline, on the 3rd week visit (last day of interference therapy) and on the 7th week visit)
  • Change in 10 meter walking test score(At baseline, on the 3rd week visit (last day of interference therapy) and on the 7th week visit)
  • Change in functional status levels according to Western Ontario and McMaster Universities Arhtiritis Incex (WOMAC) scale(At baseline, on the 3rd week visit (last day of interference therapy) and on the 7th week visit)

Study Sites (1)

Loading locations...

Similar Trials